Abstract
Background: COVID-19 reached Brazil in February 2020 after spreading throughout Asia and Europe. The disease first struck in Brazil major cities, affecting high-income groups, subsequently spreading to the socially-vulnerable outlying areas. The objective of this preliminary study was to the estimate the seroprevalence of COVID-19 in the Baixada Santista Metropolitan Area - RMBS, to inform policies for prevention and preparation of primary care, hospital services, hospital beds, intensive and critical care in a bid to reduce lethality. Methods: This study is the first of a four-phase cross-sectional survey to include all cities within the Baixada Santista metropolitan area. The probabilistic population-based sample was based on a 7% prevalence with a 2% delta, a 5% level of significance and 90% power, and considered the estimated population, stratified by age, gender and city. The sample was randomized in each city and street selection was based on data drawn from the 2010 Brazilian census. The serology test was chosen from the available test kits approved by the National Health Agency (ANS) of the National Health Surveillance Agency (ANVISA), for the detection of SARS-CoV-2 antibodies. Information on socioeconomic characteristics, health service use, symptoms and adherence to social distancing measures was collected. All variables were expressed as absolute and relative frequencies and confidence intervals. Results: The final sample comprised 2,342 respondents with a mean age of 37.78 (19.98) years and equal gender distribution. Respondents predominantly lived in an abode with 4 or more rooms, 71.9% had an income of ≤3 minimum wages and no formal employment. Over half of the sample reported being reliant on the National Health Service (SUS) for health care, while 26.5% held private health insurance. Social distancing was practiced by 61.4% of respondents who answered this question. Seroprevalence measured was 1.4% for a 95% CI (0.93-1.93) based on mathematical estimates, with a ratio of 15 actual infections for every case notified, and lethality of 0.48%. Conclusion: Results revealed a flattening of the epidemiological curve in the region and high underreporting of cases.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The Financing will be carried out by the Baixada Santista Metropolitan Development Fund, according to resolution 008-2020 of the Baixada Santista Metropolitan Development Council, CONDESB. The amount transferred will be exclusively for the purchase of the Quick Tests, in the limit of R $ 1,976,442.92, published in the Official Gazette of the State of Sao Paulo on April 24, 2020
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the committee of the Lusiada University, Santos, Sao Paulo state, under permit no. 3.992.985. All participants signed the Free and Informed Consent form. www.lusiada.br
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data can be requested by e-mail mcaseiro@uol.com.br
